<DOC>
	<DOCNO>NCT00816543</DOCNO>
	<brief_summary>The primary objective trial : - To determine whether feasible locally advanced gastric gastroesophageal cancer administer 3 cycle Docetaxel , Oxaliplatin S-1 chemotherapy scheme also determine toxicity involve . The secondary objective trial describe : - The disease free survival one two year subgroup patient undergone R0 resection . - The downstaging 3 cycle chemotherapy , pCR subgroup patient undergone R0 resection progression-free survival overall survival one two year .</brief_summary>
	<brief_title>Docetaxel + Oxaliplatin + S-1 Potentially Operable Gastric Gastroesophageal Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Inclusion criterion : Patients histologically confirm , newly diagnose , localize gastric gastroesophageal adenocarcinoma , consider operable . The bulk disease must localize stomach , although gastroesophageal junction may involve . Patients T3 T4 carcinoma without ( N0 ) T2 T3 T4 regional lymph node involvement assess EUS , peritoneal seeding suspect abdomenpelvic CT confirm laparoscopy . Performance status 01 ECOG scale Adequate haematological function liver kidney function within 7 day prior enrollment : Absolute neutrophil count &gt; = 1.5 x 10^9/L Platelets &gt; = 100 x 10^9/L Haemoglobin &gt; 10 g/dl Calculated creatinine clearance &gt; = 60 ml/min Total bilirubin &lt; = 3 x UNL GOT GPT &lt; = 3 x UNL Exclusion Criteria Previous surgery primary tumour Prior palliative surgery ( open closure , passage operation ) Any type tumour ( e.g . leiomyosarcoma , lymphoma ) secondary malignancy , except basal cell skin carcinoma basal cell carcinoma situ cervix already successfully treat Distant metastasis ( M1 ) include distant nodal Groups ( Retropancreatic , paraaortic , portal , retroperitoneal , mesenteric node ) Any previous palliative , adjuvant neoadjuvant chemotherapy and/or radiotherapy Simultaneous therapy antitumour drug Ileus , chronic inflammatory intestinal disease extensive resection small intestine disorder limit drug resorption . This include gastric dump syndrome , indication accelerate passage small intestine , indication resorption disorder intestinal surgery Evidence gastric outlet obstruction /or severe tumor hemorrhage Other anamnestic reaction , serious illness medical condition : Unstable , persistent cardiac disease despite medicinal treatment , myocardial infarction within 6 month start trial Chronic diarrhoea Neurological psychological disorder include dementia seizure Active , noncontrollable infection sepsis Actively disseminate intravascular coagulation Symptomatic peripheral neuropathy NCI CTC version 3.0 grade &gt; = 1 Hypersensitivity study drug Patients anticoagulant therapy warfarin coumarines exclude participation . Pregnant lactating ( case potentially childbearing woman , pregnancy test positive ) Patients childbearing age potential father child refuse use adequate contraception Drug , substance alcohol abuse The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>